REVOLUTIONIZING CANCER TREATMENT AND PATIENT CARE
Chimeric Antigen Receptor (CAR) technology is the new frontier in immunotherapy. Immune cells are removed from the body, genetically modified to recognize cancer biomarkers, and then infused back into the patient. This novel therapy supercharges the patient’s immune system to effectively recognize and destroy cancer cells.
A complete adoptive immunotherapy using CAR technology to recognize and destroy cancer cells.
A new genetically modified immune cell – MOTO-CAR™ to target unique biomarkers on the surface of malignant tumor cells.
A companion diagnostic/prognostic assay for CAR immunotherapies using proprietary antibodies to target cancer biomarkers.
Our Adoptive Immunotherapy
Recognize and destroy malignant tumor cells with our genetically modified immune cells.
Our Companion Diagnostic/Prognostic Assay
Determine stage of cancer and effectiveness of treatment with our proprietary ELISA assay.
Our Antibody Stain
Detect malignant cancer cells with our monoclonal antibody stain.
CURING CANCER IS A REALITY
We genetically modify immune cells to recognize and destroy malignant tumor cells.